Dr Satvika Garg, PHD in Washington, DC - Occupational Therapist

Dr Satvika Garg, PHD is a Occupational Therapist based in Washington, District Of Columbia. Dr Satvika Garg is licensed to practice in District Of Columbia (license number OT010001052) and her current practice location is 111 Michigan Ave Nw, Washington, District Of Columbia. She can be reached at her office (for appointments etc.) via phone at (202) 476-5000.

NPI number for Dr Satvika Garg is 1346742004 and her current mailing address is 5500 Friendship Blvd Apt 2217n, Chevy Chase, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1346742004.

Contact Information

	Dr Satvika Garg, PHD
	111 Michigan Ave Nw, Washington, DC 20010-2916
	(202) 476-5000
	Not Available

Healthcare Provider's Profile

Full Name	Dr Satvika Garg
Gender	Female
Speciality	Occupational Therapist
Location	111 Michigan Ave Nw, Washington, District Of Columbia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1346742004
Provider Enumeration Date: 03/08/2018
Last Update Date: 03/08/2018

Medical Identifiers

Medical identifiers for Dr Satvika Garg such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346742004	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	OT010001052 (District Of Columbia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Satvika Garg is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Satvika Garg, PHD 5500 Friendship Blvd Apt 2217n, Chevy Chase, MD 20815-7277 Ph: (781) 350-8058	Dr Satvika Garg, PHD 111 Michigan Ave Nw, Washington, DC 20010-2916 Ph: (202) 476-5000

News Archive

A new hydrogel for treatment and recovery of muscle injuries

A team from the Universitat Politècnica de València (UPV) and the CIBER Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) has designed and tested, at a preclinical level, a new biomaterial for the treatment and recovery of muscle injuries.

African scientists' search for female-controlled microbicide gel to prevent HIV continues

AllAfrica.com examines efforts by African researchers to develop a female-controlled HIV prevention method, writing, "Scientists searching for a gel or vaccine that can prevent HIV infection ride a rollercoaster of hope and disappointment." The article profiles efforts by researchers from the Centre for the AIDS Program of Research in South Africa (Caprisa) to find a microbicide gel to protect women from HIV infection.

First-in-human study shows positive results for new medicine that could reduce maternal deaths

The Monash University Institute of Pharmaceutical Sciences today announced positive results from a first-in-human study of a new, inhaled form of a medicine that could significantly reduce maternal deaths around the world.

Study shows female drinkers face greater risks to health compared with male drinkers

The increased risk of death associated with alcohol intake is not the same for men and women. A study that compared the amount of alcohol consumed and death from all causes among nearly 2.5 million women and men showed that the differences between the sexes became greater as alcohol intake increased, as described in an article in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

GFT505 demonstrates dose-dependent efficacy on primary endpoint in phase 2 NASH trial

GENFIT, today announces topline results of the phase 2 GOLDEN-505 trial in NASH. Due to the unexpected rate of resolution of NASH in patients randomized to placebo who had early NASH (NAS of 3, placebo response rate>57%), along with the high number of sites for a limited sample size, the study as initially designed did not enable the trial to meet directly the primary endpoint.

Occupational Therapist in Washington, DC

Miss Samora Casimir, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6900 Georgia Ave Nw, Washington, DC 20307 Phone: 443-802-7824
Petra Doyle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 8th St Ne, Suite 301, Washington, DC 20002 Phone: 202-544-5439
Lisa George, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4400 Jenifer St Nw, Suite 280, Washington, DC 20015 Phone: 202-244-8089
Andrea L. Meehan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-745-8000
Samantha Fulp, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 T St Ne, Washington, DC 20002 Phone: 956-278-0770
Tsegie Kassahun, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1818 Newton St Nw, Washington, DC 20010 Phone: 202-328-7400
Dr. Nikia Brocks, OTD,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2411 32nd St Se, Washington, DC 20020 Phone: 202-575-5404 Fax: 301-576-5404

Dr Satvika Garg, PHD - Occupational Therapist in Washington, DC